drugset / Trial / NCT00220532
Folate and Protection Against Cervical Cancer
Phase 1/2
Terminated
180 enrolled
Sheffield Teaching Hospitals NHS Foundation Trust
World Cancer Research Fund International · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
This is a randomised double-blind placebo-controlled trial to see whether giving a low dose of the vitamins folic acid and riboflavin is beneficial to women who have very low grade abnormalities of the cervical cells.
Timeline
- Start
- 2005-07
- Primary completion
- —
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Riboflavin | Other / unclassified | 5 mg | — |
| Subject | folic acid | Other / unclassified | 1.2 mg | — |